NCT07364825

Brief Summary

The goal of this pilot randomized controlled trial is to learn if adult patients with acute psychiatric conditions can receive hospital-level care at home. The main question it aims to answer is: 1\. Estimate the eligibility rate for BHH among screened patients. What percentage of eligible patients agree to enroll in behavioral health home hospital (intervention)?

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Jan 2026May 2026

Study Start

First participant enrolled

January 5, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 23, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 22, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Expected
Last Updated

May 6, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

January 7, 2026

Last Update Submit

May 5, 2026

Conditions

Keywords

behavioral health home hospitalhome hospitalhospital in the homehospital at home

Outcome Measures

Primary Outcomes (2)

  • Patient eligibility rate

    Eligibility rate for BHH for patients who are screened.

    On the date of patient recruitment, expected one day

  • Reasons for patient ineligibility

    Reasons for ineligibility, percent

    On the date of patient recruitment, expected one day

Secondary Outcomes (3)

  • Patient decline rate and reasons for declining

    Date of patient admission, expected one day

  • Retention Rate - complete follow-up

    Day of discharge to 30 days later

  • Retention rate - 30 day post discharge survey

    Day of discharge to 30 days later

Other Outcomes (167)

  • Time between patient being approached by RA and consent signature

    Date of enrollment, expected one day

  • Caregiver decline rate and reasons for declining

    Date of patient admission, expected one day

  • Patients' perceptions and attitudes towards their hospitalization

    Date of discharge to 30 date after discharge, assessed up to 2 months

  • +164 more other outcomes

Study Arms (2)

Behavioral health home hospital Care

EXPERIMENTAL

Patients receive hospital level psychiatric care in their home

Other: Behavioral Health Home Hospital

Quasi control group

NO INTERVENTION

Patients receive hospital level psychiatric care in the traditional brick-and-mortar hospital

Interventions

Patients receive hospital level psychiatric care in their home

Behavioral health home hospital Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥18 years old
  • Resides or will reside during hospital care within a 10-mile geographic area surrounding BWFH or BWH.
  • Patients must be able to be safely managed at home with the in-home clinical coverage and monitoring provided by the BHH program, as determined by the BHH MD. If the BHH MD determines that caregiver support is required for safe participation, the patient must have a caregiver who is able to provide the required level of support to be eligible for enrollment. The level of caregiver support will be determined on a case-by-case basis by the patient's clinical team and BHH MD based on the patient's clinical presentation, safety needs, and functional status (see section 6.1 for details)
  • To participate in the study, the patient must agree to the level of in-home support and monitoring determined by the study doctor and clinical team. This could include the possibility of asking the patient to agree to be in the same home with their caregiver 24/7 during their entire hospitalization.
  • Voluntarily consent to BHH admission (patient or proxy consent; if proxy consents, patient assents)
  • Requires hospital-level care for anxiety/depression, psychosis, or behavioral and psychological symptoms of dementia (BPSD)
  • No current restraint use
  • No catatonia
  • Has capacity to consent OR can assent to study and has proxy who can consent Does not need in person socialization that cannot be provided remotely
  • Can reliably communicate with the BHH team (self or caregiver)
  • Does not need safety monitoring more frequently than every 30 minutes
  • Medical condition(s) manageable by BHH
  • Is not a risk of harm to others, and meets the following criteria:
  • Has not harmed staff in the past
  • Consider excluding for a score \>1 on the Broset Violence Checklist
  • +28 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

McLean Hospital

Belmont, Massachusetts, 02478, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Brigham and Women's Faulkner Hospital

Jamaica Plain, Massachusetts, 02130, United States

Location

Related Publications (1)

  • Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17.

    PMID: 31842232BACKGROUND

MeSH Terms

Conditions

Psychotic DisordersAnxiety DisordersDepressionBehavior

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersBehavioral Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 7, 2026

First Posted

January 23, 2026

Study Start

January 5, 2026

Primary Completion

April 22, 2026

Study Completion (Estimated)

May 30, 2026

Last Updated

May 6, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations